Outcome variable | OR for difference of 1 year during stage 1 (mental health only intervention) | OR for difference of 1 year during stage 2 (NASF programme) | Significance of difference in ORs stage 2 vs stage 1 | ||||
OR | 95% CI | P value | OR | 95% CI | P value | P value† | |
Mental disorder recorded in patients visiting primary care: | |||||||
During visit | 1.13 | 1.11 to 1.14 | <0.001 | 0.95 | 0.94 to 0.95 | <0.001 | <0.001 |
During year | 1.10 | 1.09 to 1.11 | <0.001 | 0.97 | 0.97 to 0.98 | <0.001 | <0.001 |
Incident diagnosis during year | 0.99 | 0.98 to 1.00 | 0.012 | 0.93 | 0.92 to 0.93 | <0.001 | <0.001 |
Antidepressants prescribed in patients with diagnosis of anxiety or depression: | |||||||
Any antidepressant during visit | 1.07 | 1.05 to 1.09 | <0.001 | 1.05 | 1.04 to 1.06 | <0.001 | 0.172 |
Any antidepressant during year | 1.13 | 1.10 to 1.15 | <0.001 | 1.07 | 1.06 to 1.08 | <0.001 | <0.001 |
Incident antidepressant treatment during year | 1.00 | 0.97 to 1.02 | 0.655 | 1.03 | 1.00 to 1.04 | <0.001 | 0.024 |
SSRI during visit | 1.14 | 1.12 to 1.18 | <0.001 | 1.09 | 1.08 to 1.10 | <0.001 | <0.001 |
SSRI during year | 1.18 | 1.16 to 1.21 | <0.001 | 1.10 | 1.09 to 1.12 | <0.001 | <0.001 |
Tricyclic during visit | 1.03 | 1.00 to 1.06 | <0.001 | 0.94 | 0.92 to 0.95 | <0.001 | <0.001 |
Tricyclic during year | 1.06 | 1.03 to 1.09 | <0.001 | 0.94 | 0.93 to 0.95 | <0.001 | <0.001 |
*All models also adjusted for age, sex, clinic and intraclass correlation of outcomes within individuals.
†P value for year–stage interaction.
SSRI, selective serotonin reuptake inhibitor.